Skip to main content

Abstract

The current experiment was conducted to evaluate and compare the efficacy of two different probiotics Bacillus subtilis WB60 and Lactobacillus plantarum KCTC3928 in diet of Japanese eel, Anguilla japonica. Seven experimental diets were formulated to contain no probiotics (CON), three graded levels of B. subtilis at 106 (BS1), 107 (BS2), 108 (BS3) and L. plantarum at 106 (LP1), 107 (LP2), 108 (LP3) CFU/g diet. Twenty fish averaging 8.29 ± 0.06 g were distributed in to 21 aquaria and were randomly assigned to one of the experimental diets in triplicate groups. Average weight gain (WG), feed efficiency (FE), and protein efficiency ratio (PER) of fish fed B. subtilis at 107 (BS2) and 108 (BS3) CFU/g diet were significantly higher than those of fish fed other experimental diets (P < 0.05). Nonspecific enzymatic activities including lysozyme, superoxide dismutase (SOD), myeloperoxidase (MPO) from fish fed B. subtilis at 107 (BS2) and 108 (BS3) CFU/g diet were detected to be significantly higher than that from fish fed CON diet (P < 0.05). Whereas, level of intestine glyceraldehyde-3-phosphate dehydrogenase (GAPDH), heat shock protein 70, 90 (HSP70, 90) and immunoglobulin (IgM) from fish fed B. subtilis at 107 and 108 CFU/g diet were recorded to be significantly higher than those of fish fed other experimental diets (P < 0.05). Parameters for intestinal morphology and histology suggested a healthier gut for the fish fed108 (BS3) CFU/g diet as compared to other treatment groups. Whereas, results from the disease challenge test with bacteria Vibrio angulillarum showed significantly lower survival rate for fish fed CON diet than those of fish fed other experimental diets. Therefore, these results indicated that oral supplement of B. subtilis at 108 (BS3) CFU/g diet could be a more effective source of probiotic compared to L. plantarum in Japanese eel.

Keywords: Bacillus; Disease resistance; Immune; Japanese eel; Lactobacillus; Probiotics.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus coagulans LactoSpore 1 billion CFUEnhanced Disease ResistanceBeneficial
Large
Bacillus coagulans LactoSpore 1 billion CFUImproved Growth PerformanceBeneficial
Large
Bacillus coagulans LactoSpore 1 billion CFUImproved Immune ResponseBeneficial
Large
Bacillus coagulans LactoSpore 1 billion CFUImproved Intestinal FunctionBeneficial
Large
Bacillus subtilis SNZ-1972Enhanced Disease ResistanceBeneficial
Large
Bacillus subtilis SNZ-1972Improved Growth PerformanceBeneficial
Large
Bacillus subtilis SNZ-1972Improved Gut HealthBeneficial
Large
Bacillus subtilis SNZ-1972Improved Immune ResponseBeneficial
Large

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.